[go: up one dir, main page]

AR002727A1 - El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion. - Google Patents

El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion.

Info

Publication number
AR002727A1
AR002727A1 ARP960101944A AR10194496A AR002727A1 AR 002727 A1 AR002727 A1 AR 002727A1 AR P960101944 A ARP960101944 A AR P960101944A AR 10194496 A AR10194496 A AR 10194496A AR 002727 A1 AR002727 A1 AR 002727A1
Authority
AR
Argentina
Prior art keywords
ridogrel
preparing
manufacture
pharmaceutical composition
treatment
Prior art date
Application number
ARP960101944A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR002727A1 publication Critical patent/AR002727A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con el uso de ridogrel para la fabricación de un medicamento para el tratamiento de enfermedades digestivasinflamatorias, donde se administra ridogrel en una dosis diaria que oscila entre 0,01 mg/kg de peso corporal y 0,5 mg/kg de peso corporal; una composiciónfarmacéutica que comprende ridogrel y un procedimiento para preparar dicha composición farmacéutica.
ARP960101944A 1995-03-28 1996-03-27 El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion. AR002727A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95200768 1995-03-28

Publications (1)

Publication Number Publication Date
AR002727A1 true AR002727A1 (es) 1998-04-29

Family

ID=8220134

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101944A AR002727A1 (es) 1995-03-28 1996-03-27 El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion.

Country Status (10)

Country Link
EP (1) EP0817631A2 (es)
JP (1) JPH10511097A (es)
AR (1) AR002727A1 (es)
AU (1) AU5397496A (es)
CA (1) CA2215160A1 (es)
HU (1) HUP9900309A3 (es)
IL (1) IL117670A (es)
NO (1) NO974486L (es)
WO (1) WO1996030016A2 (es)
ZA (1) ZA962461B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
WO2002072069A1 (en) * 2001-03-12 2002-09-19 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
WO2010091892A2 (en) 2009-02-16 2010-08-19 Giuliani International Limited Alkylamido compounds and uses thereof
US9682923B2 (en) 2012-02-09 2017-06-20 Nogra Pharma Limited Methods of treating fibrosis
BR112014026160A2 (pt) 2012-04-18 2017-07-18 Nogra Pharma Ltd métodos para tratar intolerância à lactose
WO2017046343A1 (en) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions for rectal administration in the treatment of ulcerative colitis and methods of using same
EP3921299B1 (en) 2019-02-08 2024-11-20 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Also Published As

Publication number Publication date
WO1996030016A3 (en) 1997-01-30
HUP9900309A2 (hu) 1999-05-28
WO1996030016A2 (en) 1996-10-03
IL117670A0 (en) 1996-07-23
AU5397496A (en) 1996-10-16
IL117670A (en) 2000-02-29
NO974486D0 (no) 1997-09-29
ZA962461B (en) 1997-09-29
NO974486L (no) 1997-09-29
JPH10511097A (ja) 1998-10-27
EP0817631A2 (en) 1998-01-14
HUP9900309A3 (en) 1999-11-29
MX9707394A (es) 1997-11-29
CA2215160A1 (en) 1996-10-03

Similar Documents

Publication Publication Date Title
CA2237306C (en) Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
MX171191B (es) Composiciones farmaceuticas de glipizida
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
ATE138562T1 (de) Transmukosale dosisform
MX9400287A (es) Procedimiento para la preparacion de un medicamento util para el tratamiento de la enfermedad de parkinson
ES2188782T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
KR880011199A (ko) 신규 펩타이드 화합물, 그의 제조방법 및 그를 함유하는 약학적 조성물
ES2173641T3 (es) Composicion de derivados opiaceos para la fabricacion de medicamentos.
KR970025615A (ko) 암 전이 억제제
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
AR002727A1 (es) El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion.
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
AR006202A1 (es) Usos de antagonista ige para preparar un medicamento util para el tratamiento de las enfermedades alergicas y composiciones que los contiene
US4515802A (en) Analgesic preparations
BR0107881A (pt) Uso de fsh tratamento de infertilidade
HUP0101514A2 (hu) Készítmény és eljárás gyulladásos bélbetegség kezelésére N-acetilglükózamin vastagbélbe történő adagolásával
Srivastava Pharmacology: A book of achieving knowledge for drugs
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
BE1002256A3 (fr) Medicaments.
JPS59116219A (ja) 中枢鎮痛剤とビタミンｂ１２又はその誘導体との組合せを活性成分として含む新規な鎮痛剤組成物
KR910007528A (ko) 벤조디아제핀 및 페닐피릴케톤 유도체의 용도
GB2135884A (en) Analgesic preparations containing tizanidine and paracetamol